MGNX (STOCKS)
MacroGenics, Inc.
$1.710000
-0.010000 (-0.58%)
Prev close: $1.720000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric Risser
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $108.80M
- Employees
- 341
- P/E (TTM)
- -1.42
- P/B (TTM)
- 1.62
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.27 | $-0.50 | +0.7715 | +153.84% |
|
Jun 2025 (Q2)
|
$-0.57 | $-0.62 | +0.0502 | +8.09% |
|
Mar 2025 (Q1)
|
$-0.65 | $-0.80 | +0.1475 | +18.50% |
|
Dec 2024 (Q4)
|
$-0.25 | $-0.44 | +0.1949 | +43.81% |
Financial Statements
| Revenues | $127.63M |
| Benefits Costs and Expenses | $204.05M |
| Cost Of Revenue | $233.00K |
| Costs And Expenses | $241.21M |
| Operating Expenses | $240.98M |
| Research and Development | $152.09M |
| Other Operating Expenses | $88.89M |
| Operating Income/Loss | -$113.58M |
| Income/Loss From Continuing Operations After Tax | -$75.89M |
| Income/Loss From Continuing Operations Before Tax | -$74.84M |
| Income Tax Expense/Benefit | $1.05M |
| Interest Expense, Operating | $4.21M |
| Net Income/Loss | -$75.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$75.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$75.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.20 |
| Diluted Earnings Per Share | -$1.20 |
| Basic Average Shares | 189,389,200 |
| Diluted Average Shares | 189,439,558 |
| Assets | $270.76M |
| Current Assets | $232.09M |
| Inventory | $8.75M |
| Other Current Assets | $223.34M |
| Noncurrent Assets | $38.67M |
| Fixed Assets | $13.98M |
| Other Non-current Assets | $24.70M |
| Liabilities | $203.76M |
| Current Liabilities | $44.47M |
| Accounts Payable | $5.94M |
| Other Current Liabilities | $38.53M |
| Noncurrent Liabilities | $159.29M |
| Equity | $67.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $67.00M |
| Liabilities And Equity | $270.76M |
| Net Cash Flow From Operating Activities | -$162.47M |
| Net Cash Flow From Operating Activities, Continuing | -$162.47M |
| Net Cash Flow From Investing Activities | -$6.64M |
| Net Cash Flow From Investing Activities, Continuing | -$6.64M |
| Net Cash Flow From Financing Activities | $69.61M |
| Net Cash Flow From Financing Activities, Continuing | $69.61M |
| Net Cash Flow | -$99.50M |
| Net Cash Flow, Continuing | -$99.50M |
| Comprehensive Income/Loss | -$75.88M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$75.90M |
| Other Comprehensive Income/Loss | $1.40M |